Find Unlimited Emails.For Free.

Discover prospects, find their business emails, and build your pipeline with Unifers.

Start for Free

Stanislav Praslov

Global Leadership Panel Member @Fight Cancer Global

Mannheim, DE
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

May 2019 — Present

Global Leadership Panel Member @Fight Cancer Global

DE

EDUCATION

2000 — 2001

Emory University School of Medicine

Internal Medicine Observership program

N/A

Voronezh State Medical University named after N.N. Burdenko.

M.D., Internal Medicine

SKILLS

Clinical TrialsOncologyProtocolNeurologyRegulatory AffairsLifesciencesGood Clinical Practice (Gcp)Drug DevelopmentCancerGcpU.s. Food and Drug Administration (Fda)MedicineInfectious DiseasesIch-GcpOncology Clinical ResearchPharmacovigilanceMedical AffairsClinical Data ManagementOracle ClinicalClinical OperationsHematologyTrial ManagementEndocrinologyDermatologyStandard Operating Procedure (Sop)Medical WritingClinical ResearchVaccinesRegulatory SubmissionsClinical Research AssociatesClinical MonitoringClinical Trial Management System (Ctms)CROCrf DesignBiotechnologyClinical Study DesignEdcTherapeutic AreasCtmsCardiology

ABOUT STANISLAV PRASLOV

I am an MD and Clinical Pharmacologist with 20+ years of experience in clinical trials, specializing in medical oversight, safety evaluation, and source data review. Over the past decade, I have conducted GCP and GxP audits for global pharmaceutical companies, focusing on high‑risk and safety‑critical areas.My current focus is MD‑led clinical trial audits, providing medical review of Inclusion/Exclusion decisions, AE/SAE assessment, safety data integrity, and endpoint verification. I work peer‑to‑peer with investigators to evaluate clinical judgment, identify medically relevant deviations, and strengthen subject protection and inspection readiness.With a solid background in GxP, QMS (CQI IRCA Lead Auditor: ISO 9001 & 13485), pharmacovigilance, and clinical operations, I bridge clinical insight with regulatory expectations and support sponsors in complex or high‑risk studies, either independently or in collaboration with a network of experienced MD auditors.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.